MetLife Investment Management’s Exelon EXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.7M | Sell |
238,810
-3,387
| -1% | -$158K | 0.06% | 318 |
|
|
2025
Q4 | $10.6M | Sell |
242,197
-8,411
| -3% | -$384K | 0.05% | 340 |
|
|
2025
Q3 | $11.3M | Sell |
250,608
-6,645
| -3% | -$292K | 0.05% | 327 |
|
|
2025
Q2 | $11.2M | Sell |
257,253
-3,745
| -1% | -$167K | 0.07% | 285 |
|
|
2025
Q1 | $12M | Sell |
260,998
-4,885
| -2% | -$204K | 0.06% | 286 |
|
|
2024
Q4 | $10M | Buy |
265,883
+5,851
| +2% | +$227K | 0.05% | 263 |
|
|
2024
Q3 | $10.5M | Sell |
260,032
-6,712
| -3% | -$252K | 0.06% | 249 |
|
|
2024
Q2 | $9.23M | Buy |
266,744
+33,695
| +14% | +$1.24M | 0.05% | 260 |
|
|
2024
Q1 | $8.76M | Sell |
233,049
-8,572
| -4% | -$306K | 0.06% | 268 |
|
|
2023
Q4 | $8.67M | Sell |
241,621
-4,518
| -2% | -$174K | 0.06% | 250 |
|
|
2023
Q3 | $9.3M | Sell |
246,139
-6,288
| -2% | -$256K | 0.07% | 214 |
|
|
2023
Q2 | $10.3M | Sell |
252,427
-4,013
| -2% | -$166K | 0.07% | 212 |
|
|
2023
Q1 | $10.7M | Sell |
256,440
-3,073
| -1% | -$128K | 0.08% | 195 |
|
|
2022
Q4 | $11.2M | Sell |
259,513
-3,762
| -1% | -$149K | 0.09% | 188 |
|
|
2022
Q3 | $9.86M | Sell |
263,275
-777
| -0.3% | -$34.4K | 0.08% | 194 |
|
|
2022
Q2 | $12M | Sell |
264,052
-2,397
| -0.9% | -$113K | 0.09% | 169 |
|
|
2022
Q1 | $12.7M | Sell |
266,449
-36,595
| -12% | -$1.55M | 0.08% | 192 |
|
|
2021
Q4 | $12.5M | Sell |
303,044
-6,593
| -2% | -$248K | 0.1% | 156 |
|
|
2021
Q3 | $10.7M | Sell |
309,637
-7,990
| -3% | -$273K | 0.1% | 166 |
|
|
2021
Q2 | $10M | Sell |
317,627
-8,562
| -3% | -$276K | 0.09% | 184 |
|
|
2021
Q1 | $10.2M | Sell |
326,189
-5,976
| -2% | -$180K | 0.09% | 169 |
|
|
2020
Q4 | $10M | Sell |
332,165
-14,240
| -4% | -$420K | 0.09% | 171 |
|
|
2020
Q3 | $8.84M | Sell |
346,405
-10,885
| -3% | -$289K | 0.1% | 174 |
|
|
2020
Q2 | $9.25M | Buy |
357,290
+5,987
| +2% | +$159K | 0.11% | 165 |
|
|
2020
Q1 | $9.22M | Sell |
351,303
-10,749
| -3% | -$338K | 0.13% | 154 |
|
|
2019
Q4 | $11.8M | Sell |
362,052
-8,641
| -2% | -$280K | 0.12% | 157 |
|
|
2019
Q3 | $12.8M | Sell |
370,693
-4,528
| -1% | -$152K | 0.14% | 137 |
|
|
2019
Q2 | $12.8M | Sell |
375,221
-11,246
| -3% | -$397K | 0.14% | 136 |
|
|
2019
Q1 | $13.8M | Sell |
386,467
-1,246
| -0.3% | -$42.4K | 0.15% | 123 |
|
|
2018
Q4 | $12.5M | Sell |
387,713
-6,228
| -2% | -$199K | 0.15% | 125 |
|
|
2018
Q3 | $12.3M | Sell |
393,941
-4,488
| -1% | -$138K | 0.13% | 150 |
|
|
2018
Q2 | $12.1M | Sell |
398,429
-8,733
| -2% | -$250K | 0.14% | 133 |
|
|
2018
Q1 | $11.3M | Sell |
407,162
-9,315
| -2% | -$252K | 0.13% | 147 |
|
|
2017
Q4 | $11.7M | Buy |
+416,477
| New | +$12M | 0.13% | 141 |
|
Other funds holding EXC
VCM
VPM
MetLife Investment Management's EXC Position: Q1 2026 in Review
MetLife Investment Management reduced its Exelon (EXC) stake by 1.4% in Q1 2026, selling an estimated $158K and leaving 238,810 shares worth $11.7M. The position accounts for 0.06% of the portfolio, ranked #318.
MetLife Investment Management first reported a position in EXC in Q4 2017 and has held it in 34 quarters since. The position peaked at $13.8M in Q1 2019. 1,277 funds tracked by Wall St. Rank hold EXC as of Q1 2026.
- MetLife Investment Management held 238,810 shares of Exelon worth $11.7M as of Q1 2026.
- MetLife Investment Management sold 3,387 Exelon shares in Q1 2026, an estimated $158K.
- Exelon made up 0.06% of MetLife Investment Management's portfolio in Q1 2026, its #318 holding.
- MetLife Investment Management first reported a position in Exelon in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Exelon position peaked at $13.8M in Q1 2019.
- 1,277 funds tracked by Wall St. Rank held Exelon as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.